Cristin-resultat-ID: 1072257
Sist endret: 20. november 2015 12:37
NVI-rapporteringsår: 2013
Resultat
Vitenskapelig artikkel
2013

Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs

Bidragsytere:
  • Kurt Brekke
  • Dag Morten Dalen og
  • Tor Helge Holmås

Tidsskrift

European Journal of Health Economics
ISSN 1618-7598
e-ISSN 1618-7601
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2013
Publisert online: 2013
Trykket: 2014
Volum: 15
Hefte: 9
Sider: 937 - 951
Open Access

Beskrivelse Beskrivelse

Tittel

Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs

Sammendrag

This article studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries covering the period from the first launch in 2000 until becoming blockbusters in 2009. Descriptive statistics reveal large variations across countries in per-capita consumption and price levels both overall and at the brand level. We explore potential sources for the cross-country consumption differences by estimating several multivariate regression models. Our results show that large parts of the cross-country variation are explained by time-invariant country-specific factors (e.g., disease prevalence, demographics, health care system). We also find that differences in income [gross domestic product (GDP) per capita] and health spending (share of GDP) explain the cross-country variation in consumption, while relative price differences seem to have limited impact.

Bidragsytere

Kurt Richard Brekke

Bidragsyterens navn vises på dette resultatet som Kurt Brekke
  • Tilknyttet:
    Forfatter
    ved Institutt for samfunnsøkonomi ved Norges Handelshøyskole

Dag Morten Dalen

  • Tilknyttet:
    Forfatter
    ved Institutt for samfunnsøkonomi ved Handelshøyskolen BI

Tor Helge Holmås

  • Tilknyttet:
    Forfatter
    ved NORCE Samfunn ved NORCE Norwegian Research Centre AS
1 - 3 av 3